Literature DB >> 34360

Effect of ampicillin and chloramphenicol against Streptococcus pneumoniae and Neisseria meningitidis.

W E Feldman, T Zweighaft.   

Abstract

Antagonism, determined by isobolograms constructed from data from combinations of ampicillin and chloramphenicol at or below the minimal inhibitory or bactericidal concentrations, was observed against 13 clinical isolates of meningococcus and against one isolate of pneumococcus. Synergy occurred against six strains of pneumococcus and three of meningococcus. Additive effects were noted against 14 isolates of pneumococcus and 5 of meningococcus. There was no relationship between the minimal inhibitory or bactericidal concentrations for the isolates and the occurrence of antagonistic, additive, or synergistic effects. These data indicate that ampicillin and chloramphenicol may be antagonistic in vitro against some strains of pneumococcus or meningococcus.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 34360      PMCID: PMC352639          DOI: 10.1128/AAC.15.2.240

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites.

Authors:  G B ELION; S SINGER; G H HITCHINGS
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157

3.  Studies of combinations of antibiotics in vitro and in experimental infections in mice.

Authors:  E A BLISS; P T WARTH; P H LONG
Journal:  Bull Johns Hopkins Hosp       Date:  1952-02

4.  Bacteriologic studies of the newer antibiotics: effect of combined drugs on microorganisms.

Authors:  S SPICER
Journal:  J Lab Clin Med       Date:  1950-08

5.  Studies on the pathogenesis of meningitis. VI. Antagonism between penicillin and chloramphenicol in experimental pneumococcal meningitis.

Authors:  J F Wallace; R H Smith; M Garcia; R G Petersdorf
Journal:  J Lab Clin Med       Date:  1967-09

6.  Effect of ampicillin and chloramphenicol against Haemophilus influenzae.

Authors:  W E Feldman
Journal:  Pediatrics       Date:  1978-03       Impact factor: 7.124

7.  Antagonism limit of penicillin G and chloramphenicol against Neisseria meningitidis.

Authors:  E Yourassowsky; R Monsieur
Journal:  Arzneimittelforschung       Date:  1971-09

8.  In vitro effects of carbenicillin combined with gentamicin or polymyxin B against Pseudomonas aeruginosa.

Authors:  T C Eickhoff
Journal:  Appl Microbiol       Date:  1969-09
  8 in total
  6 in total

1.  Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.

Authors:  C J Easton; J R Knowles
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 2.  Chloramphenicol in the 1980s.

Authors:  I Shalit; M I Marks
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

3.  Bacteriostatic and bactericidal activities of beta-lactam antibiotics enhanced by the addition of low concentrations of gentamicin.

Authors:  G Masuda; K Nakamura; T Yajima; K Saku
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

4.  Single-dose pharmacokinetics of ceftriaxone in infants and young children.

Authors:  U B Schaad; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

5.  Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis.

Authors:  J R Perfect; S D Lang; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

6.  Cefuroxime in bacterial meningitis.

Authors:  J Pfenninger; U B Schaad; J Lütschg; A Nussbaumer; U Zellweger
Journal:  Arch Dis Child       Date:  1982-07       Impact factor: 3.791

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.